RT Journal Article
SR Electronic
T1 Assessing the impact of community-based interventions on hypertension and diabetes management in three Minnesota communities: findings from the prospective evaluation of US HealthRise programs
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.26.21262688
DO 10.1101/2021.08.26.21262688
A1 Fullman, Nancy
A1 Cowling, Krycia
A1 Flor, Luisa S
A1 Wilson, Shelley
A1 Bhatt, Paurvi
A1 Bryant, Miranda F
A1 Camarda, Joseph N
A1 Colombara, Danny V
A1 Daly, Jessica
A1 Gabert, Rose K
A1 Harris, Katie Panhorst
A1 Johanns, Casey K
A1 Mandile, Charlie
A1 Marshall, Susan
A1 McNellan, Claire R
A1 Mulakaluri, Vasudha
A1 Phillips, Bryan K
A1 Reitsma, Marissa B
A1 Sadighi, Naomi
A1 Tamene, Tsega
A1 Thomson, Blake
A1 Wollum, Alexandra
A1 Gakidou, Emmanuela
YR 2021
UL http://medrxiv.org/content/early/2021/08/29/2021.08.26.21262688.abstract
AB Background Community-based health interventions are increasingly viewed as models of care that can bridge healthcare gaps experienced by underserved communities in the United States (US). With this study, we sought to assess the impact of such interventions, as implemented through the US HealthRise program, on hypertension and diabetes among underserved communities in Hennepin, Ramsey, and Rice Counties, Minnesota.Methods and findings HealthRise patient data from June 2016 to October 2018 were assessed relative to comparison patients in a difference-in-difference analysis, quantifying program impact on reducing systolic blood pressure (SBP) and hemoglobin A1c, as well as meeting clinical targets (< 140 mmHg for hypertension, < 8% Al1c for diabetes), beyond routine care. For hypertension, HealthRise participation was associated with SBP reductions in Rice (6.9 mmHg [95% confidence interval: 0.9–12.9]) and higher clinical target achievement in Hennepin (27.3 percentage-points [9.8–44.9]) and Rice (17.1 percentage-points [0.9 to 33.3]). For diabetes, HealthRise was associated with A1c decreases in Ramsey (1.3 [0.4–2.2]). Qualitative data showed the value of home visits alongside clinic-based services; however, challenges remained, including community health worker retention and program sustainability.Conclusions HealthRise participation had positive effects on improving hypertension and diabetes outcomes at some sites. While community-based health programs can help bridge healthcare gaps, they alone cannot fully address structural inequalities experienced by many underserved communities.Competing Interest StatementFunding for the HealthRise project came from the Medtronic Foundation. PB and JD are employees of the Medtronic Foundation. CM, SM, NS, and TT are recipients of HealthRise grants from the Medtronic Foundation to implement HealthRise interventions. NF, KC, LSF, SW, MFB, JNC, DVC, RKG, KPH, CKJ, CRM, VM, BKP, MBR, BT, AW, and EG are recipients of funding from grants from the Medtronic Foundation to evaluate HealthRise interventions.Funding StatementFunding for the HealthRise project came from the Medtronic Foundation. PB and JD are employees of the Medtronic Foundation. CM, SM, NS, and TT are recipients of HealthRise grants from the Medtronic Foundation to implement HealthRise interventions. NF, KC, LSF, SW, MFB, JNC, DVC, RKG, KPH, CKJ, CRM, VM, BKP, MBR, BT, AW, and EG are recipients of funding from grants from the Medtronic Foundation to evaluate HealthRise interventions.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this study was obtained from the institutional review board of the University of Washington, as well as the local data collection agencies and government entities for each site. This research conforms to the principles embodied in the Declaration of Helsinki. All personal identifiers were removed prior to the data being sent to IHME for analysis; only de-identified data were analysed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available in a public, open access repository. The datasets generated and/or analysed during the current study are available, when possible, in the GHDx data repository, http://ghdx.healthdata.org/series/healthrise-evaluationhttp://ghdx.healthdata.org/series/healthrise-evaluation